arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Tenet Healthcare Corporation

THC Health Care Hospital/Nursing Management
$264.99
▲ +0.0% Today
as of Sep 4, 16:55 ET
Last 30 days +0.92% Jul 28 → Sep 04
$247.53 $256.45 $265.38 $274.31 $283.23 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$261.04
High
$266.00
Low
$261.13
Volume
$557,272
Avg Vol
$1M
Mkt Cap
$20.3B
P/E (TTM)
12.29
Beta
—
52w High
$283.05
52w Low
$157.58
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

Sep 4 · 15:10 Simply Wall St.
Tenet Healthcare (THC), What Is Behind The Fresh Attention?
Sep 4 · 12:55 Zacks
Fast-paced Momentum Stock Tenet (THC) Is Still Trading at a Bargain
Sep 4 · 11:05 TMX Newsfile
Tenet Publishes Q2-2026 Financial Results Q&A Transcript
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$158
$283
86% of range
Avg surprise (last 2)
+40.9%
Avg reaction (last 2)
+0.5%
50% positive
Latest IV / EM
38%
EM ±5.9% · $270 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.94$6.05$11.16$16.27$21.38 Actual $1.32Actual $1.15Actual $0.94Actual $21.38Actual $2.64Actual $4.89Actual $4.36Est $3.11Actual $4.02Est $2.84Actual $3.86Actual $8.01Actual $9.84 MarJunSepMarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$0$1.5B$3.0B$4.4B$5.9B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $9.84 — — — — financials
Tue Mar 31, 2026Mar 2026 $8.01 — — — — financials
Tue Sep 30, 2025Sep 2025 $3.86 — — — — financials
Tue Jul 22, 2025Jun/2025 $4.02 $2.84 +41.5% — -10.7% earnings
Tue Apr 29, 2025Mar/2025 $4.36 $3.11 +40.2% — +11.7% earnings
Mon Sep 30, 2024Sep 2024 $4.89 — — — — financials
Sun Jun 30, 2024Jun 2024 $2.64 — — — — financials
Sun Mar 31, 2024Mar 2024 $21.38 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.94 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.15 — — — — financials
Fri Mar 31, 2023Mar 2023 $1.32 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$5.63B$5.37B—$5.29B$5.27B$5.22B—$5.13B
Cost of revenue————————
Gross profit————————
Operating income$1.50B$1.30B—$889M$823M$943M—$1.09B
Net income$1.04B$906M—$579M$522M$622M—$681M
EPS (diluted)$9.84$8.01—$3.86$3.14$4.27—$4.89

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$2.17B$2.97B$2.88B$2.98B$2.62B$3.00B$3.02B$4.09B
Inventory$338M$343M$348M$346M$338M$344M$346M$356M
Total current assets$7.83B$8.36B$7.85B$7.81B$7.30B$7.91B$7.68B$8.76B
Total assets$30.68B$31.20B$29.68B$29.42B$28.70B$29.24B$28.94B$29.37B
Long-term debt————————
Total liabilities$21.98B$22.35B$20.70B$20.72B$20.40B$20.58B$20.39B$21.30B
Total equity$4.66B$6.71B$4.22B$4.01B$5.48B$5.88B$4.17B$5.43B

Implied volatility — last 90 days

34%42%50%58%66% Jun 07 — IV 58% · EM ±8.1%Jun 08 — IV 55% · EM ±7.2%Jun 09 — IV 53% · EM ±6.6%Jun 10 — IV 53% · EM ±6.3%Jun 11 — IV 51% · EM ±5.7%Jun 12 — IV 47% · EM ±4.8%Jun 15 — IV 58% · EM ±4.2%Jun 16 — IV 60% · EM ±3.5%Jun 17 — IV 66% · EM ±2.8%Jun 19 — IV 46% · EM ±10.3%Jun 22 — IV 47% · EM ±9.8%Jun 23 — IV 45% · EM ±9.1%Jun 24 — IV 44% · EM ±8.7%Jun 25 — IV 42% · EM ±8.3%Jun 26 — IV 43% · EM ±8.2%Jun 29 — IV 43% · EM ±7.5%Jun 30 — IV 40% · EM ±6.8%Jul 01 — IV 39% · EM ±6.5%Jul 02 — IV 39% · EM ±6.2%Jul 03 — IV 40% · EM ±6.2%Jul 06 — IV 42% · EM ±5.8%Jul 07 — IV 40% · EM ±5.3%Jul 08 — IV 43% · EM ±5.4%Jul 09 — IV 44% · EM ±5.1%Jul 10 — IV 50% · EM ±5.5%Jul 13 — IV 60% · EM ±5.0%Jul 14 — IV 57% · EM ±4.1%Jul 15 — IV 60% · EM ±3.6%Jul 16 — IV 60% · EM ±2.5%Jul 20 — IV 58% · EM ±13.8%Jul 21 — IV 58% · EM ±13.4%Jul 22 — IV 59% · EM ±13.5%Jul 23 — IV 61% · EM ±13.8%Jul 24 — IV 46% · EM ±10.1%Jul 27 — IV 41% · EM ±8.6%Jul 28 — IV 42% · EM ±8.5%Jul 29 — IV 39% · EM ±7.9%Jul 30 — IV 40% · EM ±7.8%Jul 31 — IV 42% · EM ±8.1%Aug 03 — IV 43% · EM ±7.5%Aug 04 — IV 44% · EM ±7.6%Aug 05 — IV 43% · EM ±7.3%Aug 06 — IV 41% · EM ±6.7%Aug 07 — IV 39% · EM ±6.1%Aug 10 — IV 37% · EM ±5.2%Aug 11 — IV 37% · EM ±4.9%Aug 12 — IV 38% · EM ±4.8%Aug 13 — IV 38% · EM ±4.5%Aug 14 — IV 35% · EM ±3.8%Aug 17 — IV 42% · EM ±3.5%Aug 18 — IV 45% · EM ±3.2%Aug 19 — IV 44% · EM ±2.6%Aug 20 — IV 50% · EM ±2.1%Aug 24 — IV 34% · EM ±7.2%Aug 25 — IV 38% · EM ±7.9%Aug 26 — IV 37% · EM ±7.4%Aug 27 — IV 35% · EM ±6.8%Aug 28 — IV 35% · EM ±6.7%Aug 31 — IV 34% · EM ±6.0%Sep 01 — IV 36% · EM ±6.3%Sep 02 — IV 35% · EM ±5.9%Sep 03 — IV 37% · EM ±6.0%Sep 04 — IV 38% · EM ±5.9%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in